Federal Register / Vol. 87, No. 68 / Friday, April 8, 2022 / Notices 20865 

experienced fever or other COVID-like 

symptoms in the past seven days. 

Project staff will contact households in 

which one or more participants reported 

symptoms to schedule an appointment 

to collect samples for arbovirus and 

SARS–CoV–2 molecular testing and to 

administer a AIS questionnaire about 

symptoms, exposure and health seeking 

behaviors. From previous febrile 

surveillance studies, we expect 

approximately 40% of household adults 

will respond to text messages each week 

and 10% of COPA participants will 

report acute symptoms and agree to a 

sample collection visit each year. 

Participants with a positive SARS– 

CoV–2 molecular test will be contacted 

by phone 2–4 weeks later for a COVID– 

19 Case Follow-Up questionnaire on 

symptoms, health care seeking, 

potential exposures, and outcomes of 

SARS–CoV–2 infection. We are 

expecting that 20% of participants who 

report symptoms will have a positive 

COVID–19 result and respond to this 

follow-up questionnaire. 

The central COPA questionnaires 

(Household, Individual, KAP, Mobility, 

and Vector Control) will be repeated 

among approximately 3,800 participants 

every 12 months, up to a period of five 

years. The AIS and COVID–19 FollowUp components will be renewed and 

modified annually as applicable 

according to research and funding 

priorities. This project will allow us to 

better understand the risk, perceptions, 

and burden of arboviral infections and 

COVID–19 and evaluate a communitybased approach for vector control in 38 

communities in Ponce, Puerto Rico. The 

information obtained will inform 

decision making regarding the location, 

design, content, and evaluation of future 

mosquito control interventions 

implemented in Puerto Rico. Data on 

incidence and perception of COVID–19 

disease will also be used to inform local 

control programs and fill the current 

knowledge gaps. 

CDC requests OMB approval for an 

estimated 4,309 annual burden hours. 

There is no cost to respondents other 

than the time needed to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Ponce residents from the 38 selected communities 21 years and older or emancipated minor.Household Representative questionnaire ...... 2,700 1 10/60 

Ponce residents from the 38 selected communities 1–50 years old.Individual questionnaire ................................. 3,800 1 20/60 

Ponce residents from the 38 selected communities 1–50 years old.Specimen collection ....................................... 3,800 1 5/60 

Ponce residents from the 38 selected communities 14–50 years old.Knowledge, Attitudes, and Practices questionnaire.3,090 1 15/60 

Ponce residents from the 38 selected communities 1–50 years old.Mobility questionnaire .................................... 3,800 1 10/60 

Ponce residents from the 38 selected communities 21 years and older.Vector Control questionnaire ......................... 2,500 1 10/60 

Ponce residents from the 38 selected communities 21 years and older.AIS text message ........................................... 1,000 52 0.5/60 

Ponce residents from the 38 selected communities with inclusion criteria.AIS questionnaire ........................................... 380 1 8/60 

Ponce residents from the 38 selected communities with inclusion criteria that tested 

positive for SAR–CoV–2.

COVID–19 Case Follow-Up questionnaire .... 75 1 6/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–07519 Filed 4–7–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund 

Ministerio de Salud de la Repu ́blica de 

Panama ́ (MINSA) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

cancellation of an award of 

approximately $10,000,000 for Year 1 of 

funding to MINSA. 

DATES: The notice of award was 

cancelled on 04/05/2022. 

FOR FURTHER INFORMATION CONTACT: Lily 

de Leon, Center for Global Health, 

Centers for Disease Control and 

Prevention, 18 Avenida 11–37, Zona 15, 

VHIII, 502) 23298426 or (404) 718–2645 

USA. Email: izo0@cdc.gov. 

SUPPLEMENTARY INFORMATION: On March 

9, 2022, CDC announced a single-source 

award to support MINSA to scale up 

high-impact HIV prevention, testing and 

treatment models in Panama. This 

award is cancelled in its entirety. 

Dated: April 5, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–07542 Filed 4–7–22; 8:45 am] 

BILLING CODE 4163–18–P 


jspears on DSK121TN23PROD with NOTICES1